Association of limb-salvage surgery and amputation with survival in Ewing sarcoma of bone: A population-based SEER analysis.

Authors

Kongfeng Shao, Haojie Zhu

Published in

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. Volume 52. Issue 12. Pages 112174. Sep 25, 2026. Epub Sep 25, 2026.

Abstract

Ewing sarcoma (ES) is a highly aggressive primary bone tumor requiring multimodal therapy. This study aims to provide real-world evidence on the long-term survival impact of different surgical procedures in ES of bone.
A total of 1202 patients with primary ES of bone were identified from the Surveillance, Epidemiology, and End Results database between 2000 and 2021. Survival outcomes were compared across surgical procedures using Kaplan-Meier analysis and Cox regression.
The cohort had a median age of 16 years, with a 5-year overall survival (OS) of 65.3%. Surgical procedures included limb-salvage surgery (LSS) for 36.9% of patients, local excision (LE) for 16.1%, and amputation (AMP) for 7.3%. Patients treated with LSS achieved favorable outcomes, with a 5-year OS of 77.0%. In the multivariable analysis, survival following LSS did not significantly differ from AMP (HR = 1.356, 95% CI: 0.906-2.029, p = 0.139), whereas LE (HR = 1.424, 95% CI: 1.045-1.941, p = 0.025) and lack of surgery (HR = 1.504, 95% CI: 1.183-1.912, p = 0.001) were independently associated with worse OS. Age ≥ 18 years, tumor size > 80 mm, distant disease, and absence of surgery or chemotherapy remained independent predictors of poorer survival (all p ≤ 0.001).
In this population-based analysis, LSS was associated with favorable survival, showing no significant disadvantage compared with AMP. These findings suggest that LSS may be a reasonable local control option for resectable ES when technically feasible, warranting prospective validation.

PMID:
42810023
Bibliographic data and abstract were imported from PubMed on 30 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.